Isoray’s Cesium-131 brachytherapy seeds, which is commercially known as Cesium Blu, is used in treatment of prostate cancer patients. A recent clinical study conducted by the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania on the use of Cesium Blu in 335 intermediate-risk prostate cancer patients, demonstrated excellent outcomes. The work (authored by Joshua L. Rodríguez-López, MD, Ankur K. Patel, MD, Ronald M. Benoit, MD, Sushil Beriwal, MD, Ryan P. Smith, MD is published in the January-February 2022 issue of BRACHYTHERAPY, an international multidisciplinary journal of the American Brachytherapy Society.
To
read more please visit:
Source: isoray